KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Net Income (2016 - 2025)

Historic Net Income for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $392.6 million.

  • Resmed's Net Income rose 1391.99% to $392.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 1899.33%. This contributed to the annual value of $1.4 billion for FY2025, which is 3719.79% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Net Income is $392.6 million, which was up 1391.99% from $348.5 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Net Income peaked at $392.6 million during Q4 2025, and registered a low of -$78.5 million during Q1 2021.
  • In the last 5 years, Resmed's Net Income had a median value of $227.3 million in 2022 and averaged $247.8 million.
  • Per our database at Business Quant, Resmed's Net Income tumbled by 14810.74% in 2021 and then surged by 32809.6% in 2022.
  • Over the past 5 years, Resmed's Net Income (Quarter) stood at $201.8 million in 2021, then rose by 11.48% to $224.9 million in 2022, then fell by 7.16% to $208.8 million in 2023, then skyrocketed by 65.05% to $344.6 million in 2024, then grew by 13.92% to $392.6 million in 2025.
  • Its last three reported values are $392.6 million in Q4 2025, $348.5 million for Q3 2025, and $379.7 million during Q2 2025.